SCHEMBL5606746

SCHEMBL5606746

CCCCOC(=O)/C(=C/c1ccc(O)cc1)OCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.51
ESR1 P03372 3/20 0.51
CYP1A2 P05177 2/20 0.51
MAPK1 P28482 2/20 0.51
CYP2C19 P33261 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
CYP2D6 P10635 1/20 0.51
TSHR P16473 1/20 0.51
NR1H2 P55055 1/20 0.51
RNASEL Q05823 1/20 0.51
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA7 P43166 2/20 0.47
CA9 Q16790 2/20 0.47
CA14 Q9ULX7 2/20 0.47
ABCG2 Q9UNQ0 3/20 0.45
APP P05067 1/20 0.43
MIF P14174 2/20 0.43
MEN1 O00255 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5606752 1.00 LMNA (0.51) LMNAESR1CYP1A2MAPK1CYP2C19
SCHEMBL5607409 0.94 ESR1 (0.51) LMNAESR1CYP1A2MAPK1CYP2C19
SCHEMBL5607405 0.94 ESR1 (0.51) LMNAESR1CYP1A2MAPK1CYP2C19
SCHEMBL5607541 0.94 ESR1 (0.54) LMNAESR1CYP1A2MAPK1CYP2C19
SCHEMBL5607536 0.94 ESR1 (0.54) LMNAESR1CYP1A2MAPK1CYP2C19
SCHEMBL6062332 0.91 ESR1 (0.51) LMNAESR1CYP1A2MAPK1CYP2C19
SCHEMBL5606821 0.91 ESR1 (0.51) LMNAESR1CYP1A2MAPK1CYP2C19
SCHEMBL6062328 0.91 ESR1 (0.51) LMNAESR1CYP1A2MAPK1CYP2C19
SCHEMBL5606818 0.91 ESR1 (0.51) LMNAESR1CYP1A2MAPK1CYP2C19
SCHEMBL5606474 0.91 CA12 (0.49) LMNAESR1CYP1A2MAPK1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR LMNA 1420/4885ESR1 2687/4885CYP1A2 489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.